Introduction
Leptin acts as a negative feedback signal to the hypothalamus evoking anorexia and thermogenesis. We found that chronic i.c.v. leptin infusion increased plasma leptin in Zucker obese (OZ) and lean (LZ) rats, and circulating corticosterone (CT) was reduced in OZ but increased in LZ rats. 1 Recently it was suggested that increased plasma CT after acute central leptin injection may be a counter-regulatory action to prevent leptin causing lasting hypophagia. 2 Here we: (1) determined the extent to which the effects of human (h) and murine (m) leptin on body weight and plasma CT are related to reduced food intake; (2) established the source of high circulating leptin levels seen previously 1 by using species selective RIA kits.
Methods and procedures
Male LZ and OZ rats were implanted i.c.v. with an Lshaped cannula (Alzet) connected to an osmotic pump (Alzet Model 2001) containing phosphate buffered saline (PBS, pH 7.4).
After surgery, body weight and food intake were measured daily. After 7 days of vehicle infusion, pumps were replaced (day 0) by one containing vehicle or recombinant m-or h-leptin (42 mgad) for 7 days. LZ rats given vehicle were fed ad libitum or were pair-fed (PF) with the h-leptin group. OZ rats were used as a further control. The correct placement of brain cannulae was veri®ed at necropsy. Terminal plasma leptin levels were measured using RIA kits (Biogenesis) for rat (100% cross-reactivity (CR) for m-leptin and`2% for h-leptin), mouse (`0.1% CR for h-leptin) and h-leptin (`0.2% CR for rat and m-leptin). Plasma CT was also determined.
Interscapular brown adipose tissue (BAT) and epididymal white adipose tissue (WAT) were weighed and freeze clamped. Total RNA was extracted from BAT and expression of the UCP-1 gene was analysed.
All values are expressed as mean AE s.e.m. Data were analysed by repeated measures ANOVA followed by Dunnett's test. ANOVA followed by Tukey's HSD was performed to determine P-values for plasma hormones.
Results
In LZ rats, both m-and h-leptin signi®cantly reduced food intake vs ad libitum fed control. m-Leptin and hleptin reduced food intake to similar levels (ca 67% of controls) on day 4 and beyond. Total food intake after 7 days treatment was (118.7AE 4.1 g) in PF and hleptin groups, lower than for the m-leptin treated group (125.7AE 1.5 g).
On day 7 of treatment (vs day 0), body weight was increased 13.4% in ad libitum fed LZ rats, by 0.47% in the PF group, but was reduced by 2.94% and 4.37% in m-and h-leptin treated groups, respectively. Onset of effect of h-leptin on body weight was earlier than in the PF group. Reduced body weight in m-and h-leptin treated rats vs the PF group was associated with a reduced WAT weight and increased BAT thermogenesis, as re¯ected by increased UCP-1 mRNA expression (Table 1) .
Plasma CT level increased in response to m-and hleptin but was not due to reduced caloric intake, as it was not altered by pair-feeding (Table 1) .
By using species selective RIA kits, we found that plasma leptin was raised in leptin infused rats and that the extra leptin was derived from exogenous protein ( Table 1) .
Discussion
Here, we demonstrated that leptin infused i.c.v. in LZ rats leaked to the peripheral circulation where it was detected in high concentration. Further, m-leptin was less potent than h-leptin with respect to both its anorectic and thermogenic activity. Also, chronic leptin treatment increased CT levels, which was not directly related to reduced food intake. These data support the notion that glucocorticoids suppress the effect of leptin on body weight to prevent excessive weight loss. 
